{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:01:33Z","timestamp":1778518893676,"version":"3.51.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Despite well-known harmful health effects of smoking, research supports an inverse association with some autoimmune diseases. High-titer antinuclear antibodies (ANA) are associated with autoimmune diseases, and ANA prevalence in the US increased between 1988 and 2012. Tobacco smoking decreased during those years while vaping of electronic cigarettes (e-cigarettes) increased after their introduction in 2007. Carbon monoxide (CO) may ameliorate autoimmunity, and e-cigarettes deliver much less CO than regular cigarettes. We explored interdependencies among ANA, smoking, and time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed cross-sectional data on ANA and the primary nicotine metabolite, cotinine, in 13,288 participants \u226512 years old from three time periods (1988-1991, 1999-2004, 2011-2012) of the US National Health and Nutrition Examination Survey. Smoking exposure (none, passive, active) was inferred from serum cotinine. We used logistic regression to analyze ANA prevalence, adjusted for sex, age, and race\/ethnicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Over the study periods, ANA prevalence was highest (13.3-19.2%) for nonsmokers but non-trending; lower (11.1-15.5%) for \u201cpassive\u201d smokers but steadily increasing; and even lower for active smokers but increasing from 7.4% in 1999\u20132004 to 13.3% in 2011-2012. The increases in ANA among passive and active smokers were mainly in adolescents (ages 12\u201319 years). Smokers had reduced odds of ANA in 1999-2004, with an odds ratio (OR) of 0.65 and a 95% confidence interval (CI) of 0.45-0.93, but this association was weaker in 1988-1991 (OR=0.80; 95% CI:0.52-1.22) and 2011-2012 (OR=0.82; 95% CI:0.56-1.21).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Although smoking causes harmful health effects, ANA data are consistent with smoking playing a role in decreasing autoimmunity. Recent vaping among adolescents may partially explain their large increase in ANA prevalence. The inverse ANA association with smoking strengthened between 1988-1991 and 1999-2004 but then weakened by 2011-2012. The initial strengthening was potentially because nonsmokers were exposed to progressively less CO (and\/or other components of secondhand smoke), due to tightened smoking restrictions, while the potential nicotine-associated protection against ANA may have weakened after e-cigarettes became a source. Smoking should not be recommended given its negative health impacts. However, further studies could elucidate new mechanisms, perhaps involving components of tobacco smoke or vaping, possibly enabling development of novel preventative or treatment measures.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1537043","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T04:13:44Z","timestamp":1756268024000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Decreased cigarette smoking may partially explain the increased prevalence of antinuclear antibodies in the United States"],"prefix":"10.3389","volume":"16","author":[{"given":"Gregg E.","family":"Dinse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarice R.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine G.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroll A.","family":"Co","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica T.","family":"Priest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward K. L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmy024","article-title":"Antinuclear antibodies: marker of diagnosis and evolution in autoimmune diseases","volume":"49","author":"Sur","year":"2018","journal-title":"Lab Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of hep-2 indirect immunofluorescent patterns: the international consensus on ana patterns (Icap) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00522-w","article-title":"Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases","volume":"16","author":"Bossuyt","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.05.007","article-title":"From ana to ena: how to proceed","volume":"5","author":"Damoiseaux","year":"2006","journal-title":"Autoimmun Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12969-024-01030-x","article-title":"Screening for comorbid autoimmune disease should be considered in children with ana positive juvenile idiopathic arthritis - results from the south-swedish juvenile idiopathic arthritis cohort","volume":"22","author":"Dahlberg","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"B6","article-title":"Antinuclear antibody titration and pattern are helpful in the diagnosis of systemic autoimmune rheumatic diseases","volume":"46","author":"Mohd Razi","year":"2024","journal-title":"Malays J Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.42330","article-title":"Increasing prevalence of antinuclear antibodies in the United States","volume":"74","author":"Dinse","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107376","article-title":"Expanded assessment of xenobiotic associations with antinuclear antibodies in the United States, 1988-2012","volume":"166","author":"Dinse","year":"2022","journal-title":"Environ Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/tobaccocontrol-2016-053305","article-title":"Global economic cost of smoking-attributab le diseases","volume":"27","author":"Goodchild","year":"2018","journal-title":"Tob Control"},{"key":"B10","unstructured":"Who Global Report: Mortality Attributab le to Tobacco\n          \n          2012"},{"key":"B11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/oxfordjournals.epirev.a017925","article-title":"Cotinine as a biomarker of environmental tobacco smoke exposure","volume":"18","author":"Benowitz","year":"1996","journal-title":"Epidemiol Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044829","article-title":"Secondhand Tobacco Smoke Exposure among Children under 5 Years Old: Questionnaires Versus Cotinine Biomarkers: A Cohort Study","volume":"11","author":"Mourino","year":"2021","journal-title":"BMJ Open"},{"key":"B13","unstructured":"Serum cotinine level\n          \n          2022"},{"key":"B14","unstructured":"Cotinine factsheet\n          \n          2016"},{"key":"B15","volume-title":"E-cigarette use among youth and young adults: A report of the surgeon general","year":"2016"},{"key":"B16","unstructured":"Current Cigarette Smoking among Adults in the United States\n          \n          2024"},{"key":"B17","unstructured":"Adult tobacco use\n          \n          2024"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: the fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nri803","article-title":"Effects of cigarette smoke on the immune system","volume":"2","author":"Sopori","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180481","article-title":"Association of smoking and obesity on the risk of developing primary sj\u00f6gren syndrome: A population-based cohort study","volume":"46","author":"Servioli","year":"2019","journal-title":"J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.12.003","article-title":"Effects of Tobacco Smoke on Immunity, Inflammation and Autoimmunity","volume":"34","author":"Arnson","year":"2010","journal-title":"J Autoimmun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1548","article-title":"Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and\/or thyroglobulin antibodies: A prospective study","volume":"94","author":"Effraimidis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04455.x","article-title":"Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study","volume":"77","author":"Carl\u00e9","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/20420188241256470","article-title":"Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of graves\u2019 Disease: case report","volume":"15","author":"Elsherbiny","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/antiox12071352","article-title":"Evaluation of the involvement of heme oxygenase-1 expression in discoid lupus erythematosus lesions","volume":"12","author":"Fagone","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/jci28844","article-title":"Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation","volume":"117","author":"Chora","year":"2007","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04491.x","article-title":"Therapeutic potential of carbon monoxide in multiple sclerosis","volume":"167","author":"Fagone","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.082412","article-title":"Treatment with a co-releasing molecule (Corm-3) reduces joint inflammation and erosion in murine collagen-induced arthritis","volume":"67","author":"Ferr\u00e1ndiz","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12124","article-title":"Carbon monoxide exposure improves immune function in lupus-prone mice","volume":"140","author":"Mackern-Oberti","year":"2013","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3170-7","article-title":"Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects","volume":"57","author":"Nikolic","year":"2014","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clim.2015.02.002","article-title":"Carbon monoxide-releasing molecule-A1 (Corm-A1) improves clinical signs of experimental autoimmune uveoretinitis (Eau) in rats","volume":"157","author":"Fagone","year":"2015","journal-title":"Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26223","article-title":"Involvement of the nrf2\/ho-1\/co axis and therapeutic intervention with the co-releasing molecule corm-A1, in a murine model of autoimmune hepatitis","volume":"233","author":"Mangano","year":"2018","journal-title":"J Cell Physiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/tobaccocontrol-2011-050044","article-title":"Electronic nicotine delivery systems: adult use and awareness of the \u2018E-cigarette\u2019 in the USA","volume":"22","author":"Regan","year":"2013","journal-title":"Tob Control"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntu191","article-title":"Trends in awareness and use of electronic cigarettes among us adults, 2010-2013","volume":"17","author":"King","year":"2015","journal-title":"Nicotine Tob Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.10.036","article-title":"Overview of electronic nicotine delivery systems: A systematic review","volume":"52","author":"Glasser","year":"2017","journal-title":"Am J Prev Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2020.07.026","article-title":"Trends in E-cigarette use by age group and combustible cigarette smoking histories, U.S. Adults, 2014-2018","volume":"60","author":"Bandi","year":"2021","journal-title":"Am J Prev Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.117.008178","article-title":"Electronic cigarette use prevalence, associated factors, and pattern by cigarette smoking status in the United States from nhanes (National health and nutrition examination survey) 2013-2014","volume":"7","author":"Jaber","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.26324","article-title":"Effect of pod E-cigarettes vs cigarettes on carcinogen exposure among african american and latinx smokers: A randomized clinical trial","volume":"3","author":"Pulvers","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2016-053041","article-title":"Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users","volume":"26","author":"Wagener","year":"2017","journal-title":"Tob Control"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v3i3.418","article-title":"Comparison of exhaled carbon monoxide levels and its association with nicotine dependence between electronic and tobacco cigarettes: A cross-sectional study among teenage smokers","volume":"3","author":"Raffael","year":"2023","journal-title":"Narra J"},{"key":"B41","first-page":"1","article-title":"National health and nutrition examination survey: analytic guidelines, 1999-2010","author":"Johnson","year":"2013","journal-title":"Vital Health Stat 2"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","article-title":"Estimation of average concentration in the presence of nondetecta ble values","volume":"5","author":"Hornung","year":"1990","journal-title":"Appl Occup Environ Hygiene"},{"key":"B44","unstructured":"Limit of detection\n          \n          2024"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1515\/reveh-2022-0013","article-title":"A review of the characteristic properties of selected tobacco chemicals and their associated etiological risks","volume":"38","author":"Maiyo","year":"2023","journal-title":"Rev Environ Health"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182111107","article-title":"Effects of E-cigarette flavoring chemicals on human macrophages and bronchial epithelial cells","volume":"18","author":"Morris","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217041","article-title":"Secondhand nicotine vaping at home and respiratory symptoms in young adults","volume":"77","author":"Islam","year":"2022","journal-title":"Thorax"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000003822","article-title":"Tobacco and nicotine cessation during pregnancy: acog committee opinion, number 807","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntx230","article-title":"Systemic toxicity of smokeless tobacco products in mice","volume":"21","author":"Malovichko","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186439","article-title":"Anti-dense fine speckled 70 (Dfs70) autoantibodies: correlates and increasing prevalence in the United States","volume":"14","author":"Dinse","year":"2023","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25423","article-title":"The environment, lifestyles and climate change: the many nongenetic contributors to the long and winding road to autoimmune diseases","volume":"77","author":"Miller","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/his.12225","article-title":"Antibodies are forever: A study using 12-26-year-old expired antibodies","volume":"63","author":"Argentieri","year":"2013","journal-title":"Histopathology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181ef9948","article-title":"The validity of self-reported nicotine product use in the 2001\u20132008 national health and nutrition examination survey","volume":"48","author":"Yeager","year":"2010","journal-title":"Med Care"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn301","article-title":"Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial\/ethnic groups in the United States between 1999 and 2004","volume":"169","author":"Benowitz","year":"2009","journal-title":"Am J Epidemiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2019.26.1.12","article-title":"Smoking as a preventa ble risk factor for rheumatoid arthritis: rationale for smoking cessation treatment in patients with rheumatoid arthritis","volume":"26","author":"Sungwon","year":"2019","journal-title":"J Rheum Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejphar.2014.04.019","article-title":"Attenuation of collagen induced arthritis via suppression on th17 response by activating cholinergic anti-inflammatory pathway with nicotine","volume":"735","author":"Wu","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00296-010-1549-4","article-title":"Nicotine inhibits tumor necrosis factor-\u03b1 Induced il-6 and il-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"32","author":"Zhou","year":"2012","journal-title":"Rheumatol Int"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1537043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T04:13:48Z","timestamp":1756268028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1537043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2025.1537043"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1537043","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"article-number":"1537043"}}